Close to home.
 

Health Maintenance Schedule

UPC Pediatrics-Childhood Vaccination and Health Maintenance Schedule

Click here to download a PDF of this page.

AgeActionVaccination
3-5 days after hospital dischargeCheck-upHep B at birth
1 monthCheck-upHep B
2 monthCheck-upDTaP, IPV, Rota #1, Pneumo, Hib
4 monthCheck-upDTaP, IPV, Rota #2, Pneumo, Hib
6 monthCheck-upDTaP, IPV, Hep B, Pneumo, Hib
9 monthCheck-up
1 yearCheck-upPneumo, Hepatitis A
15 monthCheck-upMMR, Var
18 monthCheck-upDTaP (If not given at 15 months), Hep A, IPV
2 yearCheck-up
3 yearCheck-upVision (as indicated)
4 yearCheck-upDTaP, IPV, MMR, Var
5 yearCheck-upVision/Hearing (as indicated)
6 yearCheck-up
8 yearCheck-up
10 yearCheck-up
12 yearCheck-upTdap, Meningococcal, HPV* (Dose one between 9-12 years, second dose 2 months after the first dose, third dose 6 months after the first dose.)
14 yearCheck-up
16 yearCheck-up
18 yearCheck-up
20 yearCheck-up
* For well children only. Children with chronic medical problems may need to be seen more often.


Vaccine AbbreviationBrand NameVaccine Type
DTaPDaptacel ® (Sanofi)Acellular DPT (Diphtheria, Pertussis, Tetanus)
MMRMMR (Merck)Measles/Mumps/Rubella
TdapADACEL® (Sanofi)Diphtheria/Tetanus/Pertussis
Var Varivax® (Merck)Varicella (chicken pox)
Hep AVaqta® (Merck) Hepatitis A
IPVIPOL ® (Sanofi)Injectable Polio Vaccine
Pneumo Pneumovax23® (Merck)Pneumoccoccal Vaccine
Hep BRecombivax® (Merck)Hepatitis B
HibActHib® (Sanofi)Haemophilus B
MeningococcalMenactra® (Sanofi)Meningitis Vaccine
RotaRotarix® (GSK)Rotavirus Vaccine
HPVGardisil® (Merck)Human Papilloma Virus
DTaP+IPV+HibPentacel® Sanofi)Combination vaccine


INFLUENZA RECOMMENDATION

General Recommendations

  • Annual influenza vaccine should be given to children ages 6 months through 8 years.
  • All children aged 6 months - 8 years that have not been vaccinated previously, should receive two doses of vaccine, either Live, attenuated influenza vaccine (LAIV) (doses separated by >6 weeks) or Trivalent inactivated influenza vaccine (TIV) (doses separated by >4 weeks

The following high risk groups/close contacts also should receive influenza vaccine.

Targeted High-Risk Populations

  • Asthma or chronic pulmonary diseases
  • Hemodynamically significant heart disease
  • Immunosuppressive disorders or therapy
  • HIV infection
  • Sickle cell and other hemoglobinopathies
  • Diseases requiring long-term aspirin therapy
  • Chronic renal disease
  • Diabetes mellitus, other metabolic diseases

Close Contacts of High-Risk Patients

  • All health care personnel in contact with patients in hospital and outpatient-care settings
  • Household contacts, including siblings and primary caregivers of high-risk children
  • Children who are members of households with high-risk adults, including those with symptomatic HIV infection
  • Providers of home care to children and adolescents in high-risk groups
  • Household contacts and out-of-home care takers of children younger than 2 years of age

Other Considerations

  • Healthy children or adolescents who wish to reduce the chance of becoming infected
  • Influenza vaccination may be considered for
    • Any child or adolescent with an underlying condition that may compromise resistance to influenza, including young age
    • Groups of persons whose close contact facilitates rapid transmission and spread of infection that may disrupt routine activities